Lineage Cell Therapeutics, Inc.'s Net Worth
-$17 Million
Who is Lineage Cell Therapeutics, Inc.?
Lineage Cell Therapeutics, Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Oncocyte Corp, and Asterias Biotherapeutics, Inc..
SEC CIK
Lineage Cell Therapeutics, Inc.'s CIK is 0000876343
Past Insider Trading and Trends
2013 was Lineage Cell Therapeutics, Inc.'s most active year for acquiring shares with 2 total transactions. Lineage Cell Therapeutics, Inc.'s most active month to acquire stocks was the month of September. 2016 was Lineage Cell Therapeutics, Inc.'s most active year for disposing of shares, totalling 2 transactions. Lineage Cell Therapeutics, Inc.'s most active month to dispose stocks was the month of January. 2013 saw Lineage Cell Therapeutics, Inc. paying a total of $50,967,034.27 for 24,923,340 shares, this is the most they've acquired in one year. In 2019 Lineage Cell Therapeutics, Inc. cashed out on 6,250,000 shares for a total of $11,140,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Oncocyte Corp (OCX) Snapshot price: $2.9201
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -28.29% | -2.38M |
$2.16 | -$5,137,942.04 | 6.04M |
Jan 2
| |||
Form 4
| -32.20% | -4.00M |
$1.66 | -$6,640,000.00 | 8.42M |
Sep 11
| |||
Form 4
| -15.33% | -2.25M |
$2.00 | -$4,500,000.00 | 12.42M |
Jul 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Asterias Biotherapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.35% | -75.77K |
—
|
—
| 21.75M |
Feb 29
| |||
Form 4
| +43,546.68% | 21.77M |
$2.34 | $50,967,034.27 | 21.82M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||